CH
Publicaties op Oncologisch.com
Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCG...
Eerstelijns Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Gevorderd Endometrial Cancer: A Gerandomiseerde, Op...
Atezolizumab plus chemotherapie bij gevorderd/recidief endometriumcarcinoom: AtTEnd fase III